Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Proteomics ; : e2300025, 2023 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-38037300

RESUMEN

Advances in technologies to isolate extracellular vesicles (EVs) and detect/quantify their cargo underpin the novel potential of these circulating particles as a liquid biopsy to understand physiology and disease. One organ of particular interest in terms of utilizing EVs as a liquid biopsy is the liver. The extent to which EVs originating from the liver reflect the functional status of this organ remains unknown. This is an important knowledge gap that underpins the utility of circulating liver derived EVs as a liquid biopsy. The primary objective of this study was to characterize the proteomic profile of EVs isolated from the extracellular space of liver tissue (LEV) and compare this profile to that of paired tissue (LH). LCMS analyses detected 2892 proteins in LEV and 2673 in LH. Of the 2673 proteins detected in LH, 1547 (58%) were also detected in LEV. Bioinformatic analyses demonstrated comparable representation of proteins in terms of biological functions and cellular compartments. Although, enriched representation of membrane proteins and associated functions was observed in LEV, while representation of nuclear proteins and associated functions was depleted in LEV. These data support the potential use of circulating liver derived EVs as a liquid biopsy for this organ.

2.
Br J Haematol ; 185(1): 65-78, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30656643

RESUMEN

Chronic lymphocytic leukaemia (CLL) remains the most common incurable malignancy of B cells in the western world. Patient outcomes are heterogeneous and can be difficult to predict with current prognostic markers. Here, we used a quantitative label-free proteomic technique to ascertain differences in the B-cell proteome from healthy donors and CLL patients with either mutated (M-CLL) or unmutated (UM-CLL) IGHV to identify new prognostic markers. In peripheral B-CLL cells, 349 (22%) proteins were differentially expressed between normal B cells and B-CLL cells and 189 (12%) were differentially expressed between M-CLL and UM-CLL. We also examined the proteome of proliferating CLL cells in the lymph nodes, and identified 76 (~8%) differentially expressed proteins between healthy and CLL lymph nodes. B-CLL cells show over-expression of proteins involved in lipid and cholesterol metabolism. A comprehensive lipidomic analysis highlighted large differences in glycolipids and sphingolipids. A shift was observed from the pro-apoptotic lipid ceramide towards the anti-apoptotic/chemoresistant lipid, glucosylceramide, which was more evident in patients with aggressive disease (UM-CLL). This study details a novel quantitative proteomic technique applied for the first time to primary patient samples in CLL and highlights that primary CLL lymphocytes display markers of a metabolic shift towards lipid synthesis and breakdown.


Asunto(s)
Regulación Neoplásica de la Expresión Génica , Leucemia Linfocítica Crónica de Células B/genética , Leucemia Linfocítica Crónica de Células B/metabolismo , Redes y Vías Metabólicas , Biomarcadores , Biopsia , Estudios de Casos y Controles , Biología Computacional , Femenino , Perfilación de la Expresión Génica/métodos , Humanos , Cadenas Pesadas de Inmunoglobulina/genética , Región Variable de Inmunoglobulina/genética , Leucemia Linfocítica Crónica de Células B/diagnóstico , Lipidómica/métodos , Ganglios Linfáticos/patología , Masculino , Espectrometría de Masas , Metabolómica/métodos , Modelos Biológicos
3.
Clin Immunol ; 173: 57-63, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27609500

RESUMEN

We have used high-resolution mass spectrometry to sequence precipitating anti-Ro60 proteomes from sera of patients with primary Sjögren's syndrome and compare immunoglobulin variable-region (IgV) peptide signatures in Ro/La autoantibody subsets. Anti-Ro60 were purified by elution from native Ro60-coated ELISA plates and subjected to combined de novo amino acid sequencing and database matching. Monospecific anti-Ro60 Igs comprised dominant public and minor private sets of IgG1 kappa and lambda restricted heavy and light chains. Specific IgV amino acid substitutions stratified anti-Ro60 from anti-Ro60/La responses, providing a molecular fingerprint of Ro60/La determinant spreading and suggesting that different forms of Ro60 antigen drive these responses. Sequencing of linked anti-Ro52 proteomes from individual patients and comparison with their anti-Ro60 partners revealed sharing of a dominant IGHV3-23/IGKV3-20 paired clonotype but with divergent IgV mutational signatures. In summary, anti-Ro60 IgV peptide mapping provides insights into Ro/La autoantibody diversification and reveals serum-based molecular markers of humoral Ro60 autoimmunity.


Asunto(s)
Autoanticuerpos/inmunología , Autoantígenos/inmunología , Región Variable de Inmunoglobulina/inmunología , ARN Citoplasmático Pequeño/inmunología , Ribonucleoproteínas/inmunología , Síndrome de Sjögren/inmunología , Autoanticuerpos/sangre , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Mapeo Peptídico , Proteoma , Síndrome de Sjögren/sangre
4.
J Autoimmun ; 57: 77-81, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25577500

RESUMEN

Recent advances in mass spectrometry-based proteomic methods have allowed variable (V)-region peptide signatures to be derived from human autoantibodies present in complex serum mixtures. Here, we analysed the clonality and V-region composition of immunoglobulin (Ig) proteomes specific for the immunodominant SmD protein subunit of the lupus-specific Sm autoantigen. Precipitating SmD-specific IgGs were eluted from native SmD-coated ELISA plates preincubated with sera from six patients with systemic lupus erythematosus (SLE) positive for anti-Sm/RNP. Heavy (H)- and light (L)-chain clonality and V-region sequences were analysed by 2-dimensional gel electrophoresis and combined de novo database mass spectrometric sequencing. SmD autoantibody proteomes from all six patients with SLE expressed IgG1 kappa restricted clonotypes specified by IGHV3-7 and IGHV1-69 H-chains and IGKV3-20 and IGKV2-28 L-chains, with shared and individual V-region amino acid replacement mutations. Clonotypic sharing and restricted V-region diversity of systemic autoimmunity can now be extended from the Ro/La cluster to Sm autoantigen and implies a common pathway of anti-Sm autoantibody production in unrelated patients with SLE.


Asunto(s)
Autoanticuerpos/inmunología , Región Variable de Inmunoglobulina/inmunología , Péptidos/inmunología , Proteoma/inmunología , Proteínas Nucleares snRNP/inmunología , Adulto , Anciano , Secuencia de Aminoácidos , Anticuerpos Antinucleares/genética , Anticuerpos Antinucleares/inmunología , Autoanticuerpos/sangre , Autoanticuerpos/genética , Electroforesis en Gel Bidimensional , Femenino , Humanos , Inmunoglobulina G/genética , Inmunoglobulina G/inmunología , Región Variable de Inmunoglobulina/genética , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/genética , Lupus Eritematoso Sistémico/inmunología , Espectrometría de Masas , Persona de Mediana Edad , Datos de Secuencia Molecular , Mutación , Péptidos/genética , Proteoma/genética , Proteómica/métodos , Homología de Secuencia de Aminoácido
5.
Clin Immunol ; 148(1): 27-34, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23644453

RESUMEN

Long-term humoral autoimmunity to RNA-protein autoantigens is considered a hallmark of systemic autoimmune diseases. We use high resolution Orbitrap mass spectrometric autoantibody sequencing to track the evolution of a Ro60-specific public clonotypic autoantibody in 4 patients with primary Sjögren's syndrome. This clonotype is specified by a VH3-23/VK3-20 heavy and light chain pairing. Despite apparent stability by conventional immunoassay, analysis of V-region molecular signatures of clonotypes purified from serum samples collected retrospectively over 7years revealed sequential clonal replacement. Prospective longitudinal studies confirmed clonotype loss and replacement at approximately three-monthly intervals. Levels of secreted anti-Ro60 clonotypes fluctuated markedly over time, despite minimal changes in clonal affinity. Our novel findings indicate a relentless turnover of short-lived clonotypic variants, masquerading as long-lived Ro60 humoral autoimmunity.


Asunto(s)
Autoantígenos/inmunología , ARN Citoplasmático Pequeño/inmunología , Ribonucleoproteínas/inmunología , Síndrome de Sjögren/inmunología , Adulto , Anciano , Autoantígenos/sangre , Autoinmunidad/inmunología , Células Clonales , Femenino , Humanos , Estudios Longitudinales , Espectrometría de Masas , Persona de Mediana Edad , Estudios Prospectivos , ARN Citoplasmático Pequeño/sangre , Estudios Retrospectivos , Ribonucleoproteínas/sangre , Análisis de Secuencia de Proteína , Síndrome de Sjögren/sangre , Síndrome de Sjögren/patología
6.
J Autoimmun ; 39(4): 466-70, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22871259

RESUMEN

Long-lived secreted autoantibody responses in systemic autoimmunity are generally regarded to be polyclonal and to express a diverse B-cell repertoire. Here, we have used a proteomic approach based on de novo sequencing to determine the clonality and V region structures of human autoantibodies directed against a prototypic systemic autoantigen, Ro52 (TRIM21). Remarkably, anti-Ro52 autoantibodies from patients with primary Sjögren's syndrome, systemic lupus erythematosus, systemic sclerosis or polymyositis were restricted to two IgG1 kappa clonotypes that migrated as a single species on isoelectric focusing; shared a common light chain paired with one of two closely-related heavy chains; and were public in unrelated patients. Targeted mass spectrometry using these uniquely mutated V region peptides as surrogates detected anti-Ro52 autoantibodies in human sera with high sensitivity and specificity compared with traditional ELISA. Mass spectrometry-based detection of specific autoantibody motifs provides a powerful new tool for analysis of humoral autoimmunity.


Asunto(s)
Autoanticuerpos/inmunología , Inmunoglobulina G/inmunología , Idiotipos de Inmunoglobulinas/inmunología , Cadenas kappa de Inmunoglobulina/inmunología , Proteoma/inmunología , Ribonucleoproteínas/inmunología , Síndrome de Sjögren/inmunología , Adulto , Anciano , Autoanticuerpos/sangre , Autoanticuerpos/genética , Autoinmunidad/genética , Estudios de Casos y Controles , Femenino , Expresión Génica/inmunología , Humanos , Inmunidad Humoral/genética , Inmunoglobulina G/sangre , Inmunoglobulina G/genética , Idiotipos de Inmunoglobulinas/sangre , Idiotipos de Inmunoglobulinas/genética , Cadenas kappa de Inmunoglobulina/sangre , Cadenas kappa de Inmunoglobulina/genética , Focalización Isoeléctrica , Masculino , Espectrometría de Masas , Persona de Mediana Edad , Péptidos/inmunología , Proteoma/genética , Ribonucleoproteínas/genética , Sensibilidad y Especificidad , Síndrome de Sjögren/sangre , Síndrome de Sjögren/diagnóstico , Síndrome de Sjögren/genética
7.
Anal Biochem ; 430(2): 108-10, 2012 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-22929699

RESUMEN

Loading controls are necessary for semiquantitative Western blotting to compensate for loading errors. Loading control methods include the reprobing of membranes with an antibody against a constitutively expressed protein or staining the membrane with a total protein stain. We compared the loading control performance of recently released Stain-Free (SF) gels with Sypro Ruby (SR) and reprobing using ß-actin. SF gels demonstrated superior performance in that they were faster, required fewer steps and consumables, and allowed the quality of electrophoresis and Western transfer to be assessed before committing to costly and time-consuming Western blots.


Asunto(s)
Actinas/química , Electroforesis en Gel de Poliacrilamida , Immunoblotting , Actinas/metabolismo , Animales , Anticuerpos/inmunología , Western Blotting , Colorantes/química , Immunoblotting/instrumentación , Compuestos Organometálicos/química , Ratas , Retina/metabolismo , Relación Señal-Ruido
8.
Arthritis Rheum ; 63(11): 3477-86, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22038404

RESUMEN

OBJECTIVE: This study was undertaken to determine the molecular characteristics of clonotypic autoantibodies in the sera of patients with primary Sjögren's syndrome (SS). This characterization is hampered by the presence of mixed anti-Ro/La specificities that may conceal clonotypic species. In order to narrow clonotypic diversity, a positive selection step was performed on a peg-like determinant of Ro 60 (termed Ro 60-peg) prior to analysis of the autoantibody proteome. METHODS: Monospecific anti-Ro 60-peg IgG were isolated by affinity purification from the sera of 7 patients with primary SS and anti-Ro/La and subjected to 2-dimensional gel electrophoresis and high-resolution orbitrap mass spectrometric sequencing. V regions of heavy and light chains were analyzed by combined database and de novo amino acid sequencing. RESULTS: Proteomic analysis revealed a Ro 60-peg-specific IgG1κ-restricted monoclonal autoantibody that was present in the sera of all patients and specified by a V(H) 3-23 heavy chain paired with a V(κ) 3-20 light chain. The public anti-Ro 60-peg clonotype was specified further by common mutations in the heavy-chain and light-chain complementarity-determining regions. Titers and relative affinities of clonotypic IgG did not vary over the course of the disease. CONCLUSION: The expression of a Ro 60-reactive public B cell clonotype in a subset of patients with primary SS as a long-lived, class-switched circulating autoantibody implies a common breach of B cell tolerance checkpoints in these patients. The unique heavy chain/light chain signature opens the possibility of tracking the development of a "forbidden" clone against a bona fide systemic autoantigen in human disease.


Asunto(s)
Autoanticuerpos/genética , Autoinmunidad/genética , Síndrome de Sjögren/genética , Adulto , Anciano , Anticuerpos Antinucleares/genética , Anticuerpos Antinucleares/inmunología , Autoanticuerpos/inmunología , Autoinmunidad/inmunología , Epítopos/genética , Epítopos/inmunología , Femenino , Humanos , Persona de Mediana Edad , Proteómica , Síndrome de Sjögren/inmunología
9.
Trends Genet ; 23(5): 238-42, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17395332

RESUMEN

The generation and analysis of mutants is central to studies of gene function in model organisms. Methods for random mutagenesis in Drosophila melanogaster have been available for many years, but an alternative approach--targeted mutagenesis using homologous recombination--has only recently been developed. This approach has the advantage of specificity, because genes of interest can be altered. One might expect with a gene-targeting approach that the frequency of background mutations would be minimal. Unfortunately, we have found that this is not the case. Although the possibility of background mutations arising during homologous-recombination-based gene targeting has been raised in the literature, it is not routinely taken into account when using this technique. Our experience suggests that it can be a considerable problem but that it has a relatively simple solution.


Asunto(s)
Drosophila melanogaster/genética , Marcación de Gen , Genes de Insecto , Recombinación Genética , Alelos , Animales , Modelos Genéticos , Mutagénesis , Mutación , Proteómica/métodos
10.
Cell Tissue Res ; 340(1): 159-68, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20177708

RESUMEN

Although the water channel protein aquaporin-1 (AQP1) is widely observed outside the rat brain in continuous, but not fenestrated, vascular endothelia, it has not previously been observed in any endothelia within the normal rat brain and only to a limited extent in the human brain. In this immunohistochemical study of rat brain, AQP1 has also been found in microvessel endothelia, probably of the fenestrated type, in all circumventricular organs (except the subcommissural organ and the vascular organ of the lamina terminalis): in the median eminence, pineal, subfornical organ, area postrema and choroid plexus. The majority of microvessels in the median eminence, pineal and choroid plexus, known to be exclusively fenestrated, are shown to be AQP1-immunoreactive. In the subfornical organ and area postrema in which many, but not all, microvessels are fenestrated, not all microvessels are AQP1-immunoreactive. In the AQP1-immunoreactive microvessels, the AQP1 probably facilitates water movement between blood and interstitium as one component of the normal fluxes that occur in these specialised sensory and secretory areas. AQP1-immunoreactive endothelia have also been seen in a small population of blood vessels in the cerebral parenchyma outside the circumventricular organs, similar to other observations in human brain. The proposed development of AQP1 modulators to treat various brain pathologies in which AQP1 plays a deleterious role will necessitate further work to determine the effect of such modulators on the normal function of the circumventricular organs.


Asunto(s)
Acuaporina 1/metabolismo , Vasos Sanguíneos/metabolismo , Barrera Hematoencefálica/metabolismo , Endotelio Vascular/metabolismo , Sistemas Neurosecretores/metabolismo , Animales , Acuaporina 1/genética , Área Postrema/irrigación sanguínea , Área Postrema/metabolismo , Vasos Sanguíneos/citología , Barrera Hematoencefálica/citología , Mapeo Encefálico , Plexo Coroideo/irrigación sanguínea , Plexo Coroideo/metabolismo , Endotelio Vascular/citología , Femenino , Inmunohistoquímica , Masculino , Eminencia Media/irrigación sanguínea , Eminencia Media/metabolismo , Sistemas Neurosecretores/irrigación sanguínea , Glándula Pineal/irrigación sanguínea , Glándula Pineal/metabolismo , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Órgano Subfornical/irrigación sanguínea , Órgano Subfornical/metabolismo
11.
J Pharm Biomed Anal ; 46(1): 58-65, 2008 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-17933477

RESUMEN

Ant sting allergy is relatively common within south-eastern Australia and is predominantly due to Myrmecia pilosula (Jack Jumper Ant, JJA). Venom immunotherapy has been shown to be effective in preventing anaphylaxis to the sting of the JJA, but analytical techniques to standardise the venom have not been validated. The purpose of this study was to develop assays to analyse JJA venom and apply these to the standardisation of venom prior to new batches being used for the diagnosis and treatment of JJA sting allergy. Venom was analysed by protein content, HPLC-UV, enzyme-linked immunosorbent assay (ELISA) inhibition, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and SDS-PAGE immunoblot. The protein content in JJA venom was adjusted so that all batches were equivalent. A HPLC-UV assay was used to quantify the relative amount of the major allergen Myr p 2 and two minor allergens Myr p 1 and Myr p 3 and allergenic potency was determined by ELISA inhibition. SDS-PAGE and SDS-PAGE immunoblot were used as qualitative tools to determine the protein profile and presence or absence of additional high molecular weight allergens not quantifiable by HPLC-UV. A standardisation procedure has been developed that complies with the requirements described in the European Pharmacopoeia. Techniques used to determine the content of some of the other minor allergens could be developed, which would further improve the standardisation methodology.


Asunto(s)
Venenos de Hormiga/inmunología , Hormigas/química , Hipersensibilidad/inmunología , Vacunas/inmunología , Alérgenos/química , Alérgenos/inmunología , Alérgenos/aislamiento & purificación , Animales , Venenos de Hormiga/química , Venenos de Hormiga/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Desensibilización Inmunológica , Electroforesis en Gel de Poliacrilamida/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Hipersensibilidad/prevención & control , Immunoblotting , Proteínas de Insectos/química , Proteínas de Insectos/inmunología , Proteínas de Insectos/aislamiento & purificación , Reproducibilidad de los Resultados , Espectrofotometría Ultravioleta/métodos , Vacunación/métodos , Vacunas/química , Vacunas/normas
12.
Arthritis Rheumatol ; 70(10): 1617-1625, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29697211

RESUMEN

OBJECTIVE: Rheumatoid factors (RFs) are associated with systemic disease in primary Sjögren's syndrome (SS) and may be pathogenic as mixed cryoglobulins. Current detection methods cannot resolve RFs at a molecular level. This study was undertaken to perform the first proteomic and transcriptomic analysis of secreted and membrane-bound IgM-RF in primary SS and identify unique heavy-chain peptide signatures for RF clonotype tracking. METHODS: Purified heavy chains of serum RFs from 15 patients with primary SS were subjected to de novo mass spectrometric sequencing. The circulating B cell Ig repertoire was determined by massively parallel sequencing of IGH RNA from matched peripheral blood mononuclear cells (n = 7). RF-specific heavy-chain third complementarity-determining region (CDR3) peptides were identified by searching RF heavy-chain peptide sequences against the corresponding IGH RNA sequence libraries. Heavy-chain CDR3 peptides were used as biomarkers to track serum RF clonotypes using quantitative multiple reaction monitoring. RESULTS: Serum RFs were clonally restricted and composed of shared sets of IgM heavy-chain variable region (Ig VH ) 1-69, 3-15, 3-7, and 3-74 subfamilies. Cryoprecipitable RFs from patients with mixed cryoglobulinemia (MC) were distinguishable from nonprecipitating RFs by a higher frequency of amino acid substitutions and identification of stereotypic heavy-chain CDR3 transcripts. Potentially pathogenic RF clonotypes were detected in serum by multiple reaction monitoring years before patients presented with MC. Levels of Ig VH 4-34 IgM-RF decreased following immunosuppression and remission of MC. CONCLUSION: Cryoprecipitable RF clonotypes linked to vasculitis in primary SS have different molecular profiles than nonprecipitating RFs, suggesting different underlying mechanisms of production. The combined omics workflow presented herein provides molecular biomarkers for tracking and removal of pathogenic RF clones.


Asunto(s)
Cadenas Pesadas de Inmunoglobulina/sangre , Leucocitos Mononucleares/fisiología , Factor Reumatoide/sangre , Síndrome de Sjögren/sangre , Adulto , Linfocitos B/metabolismo , Compuestos de Boro/metabolismo , Rastreo Celular , Femenino , Perfilación de la Expresión Génica , Humanos , Cadenas Pesadas de Inmunoglobulina/inmunología , Inmunoglobulina M/inmunología , Masculino , Espectrometría de Masas , Persona de Mediana Edad , Proteómica , Factor Reumatoide/inmunología , Síndrome de Sjögren/inmunología
13.
J Proteomics ; 155: 73-84, 2017 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-28069558

RESUMEN

Chronic lymphocytic leukemia (CLL) remains the most common leukemia in the Western world. Whilst its disease course is extremely heterogeneous (ranging from indolent to aggressive), current methods are unable to accurately predict the clinical journey of each patient. There is clearly a pressing need for both improved prognostication and treatment options for patients with this disease. Whilst molecular studies have analyzed both genetic mutations and gene expression profiles of these malignant B-cells, and as a result have shed light on the pathogenesis of CLL, proteomic studies have been largely overlooked to date. This review summarizes our current knowledge of the proteomics of CLL, and discusses some of the issues in CLL proteomic research, such as reproducibility and data interpretation. In addition, we look ahead to how proteomics may significantly help in the development of a successful treatment for this currently incurable disease.


Asunto(s)
ADN de Neoplasias , Genoma Humano , Leucemia Linfocítica Crónica de Células B , Proteoma , Proteómica , ARN Neoplásico , ADN de Neoplasias/genética , ADN de Neoplasias/metabolismo , Femenino , Humanos , Leucemia Linfocítica Crónica de Células B/genética , Leucemia Linfocítica Crónica de Células B/metabolismo , Masculino , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Proteoma/genética , Proteoma/metabolismo , ARN Neoplásico/genética , ARN Neoplásico/metabolismo
14.
Toxicon ; 47(2): 208-17, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16376960

RESUMEN

Ant sting allergy in Australia is predominantly due to the Myrmecia pilosula species complex. Gel separation of M. pilosula venom is necessary so that the allergenic importance of each component can be defined by western blotting. However, previous PAGE methods produced suboptimal resolution and the components of each band were not precisely defined. Venom was resolved in both non-reduced and reduced form by one-dimensional acid urea PAGE, SDS-PAGE and two-dimensional acid urea-SDS PAGE. Resolved peptides were extracted and analysed by HPLC-MS. Acid urea PAGE and acid urea-SDS PAGE proved more effective than SDS-PAGE for resolution of peptides smaller than 10 kDa. All of the major peptides previously observed in M. pilosula venom were observed in gel resolved venom. Venom was found to primarily consist of peptides with molecular weight <10 kDa, most of which contain disulfide bridges. SDS-PAGE of non-reduced venom clearly defined six higher molecular weight proteins between 26 and 90 kDa. An 8546 Da dimer named pilosulin 5 was observed, but pilosulin 4, a peptide recently proposed to be present in venom was not. A variant of pilosulin 4 here named pilosulin 4.1a, existing as an 8198 Da dimer, was observed and has been characterised.


Asunto(s)
Venenos de Hormiga/química , Hormigas/química , Péptidos/análisis , Péptidos/química , Proteómica , Animales , Venenos de Hormiga/metabolismo , Peso Molecular
15.
Autoimmun Rev ; 15(4): 405-10, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26804757

RESUMEN

The structures of epitopes bound by autoantibodies against RNA-protein complexes have been well-defined over several decades, but little is known of the clonality, immunoglobulin (Ig) variable (V) gene usage and mutational status of the autoantibodies themselves at the level of the secreted (serum) proteome. A novel proteomic workflow is presented based on affinity purification of specific Igs from serum, high-resolution two-dimensional gel electrophoresis, and de novo and database-driven sequencing of V-region proteins by mass spectrometry. Analysis of anti-Ro52/Ro60/La proteomes in primary Sjögren's syndrome (SS) and anti-Sm and anti-ribosomal P proteomes in systemic lupus erythematosus (SLE) has revealed that these antibody responses are dominated by restricted sets of public (shared) clonotypes, consistent with common pathways of production across unrelated individuals. The discovery of shared sets of specific V-region peptides can be exploited for diagnostic biomarkers in targeted mass spectrometry platforms and for tracking and removal of pathogenic clones.


Asunto(s)
Autoanticuerpos/inmunología , Lupus Eritematoso Sistémico/inmunología , Síndrome de Sjögren/inmunología , Animales , Humanos , Proteoma/inmunología , Proteómica , Ribosomas/inmunología
17.
J Pharm Biomed Anal ; 54(2): 303-10, 2011 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-20869831

RESUMEN

Allergy to Myrmecia pilosula (Jack Jumper Ant) venom is common in Australia, affecting ∼2.7% of some communities. Venom immunotherapy is a highly effective treatment, but for the venom to be widely distributed for clinical use, the stability and shelf-life of formulated Jack Jumper Ant venom must be demonstrated. HPLC-UV, ELISA Inhibition, SDS-PAGE and SDS-PAGE Immunoblot were used to assess venom stability under conditions of varying temperature, pH and in the presence of various stabilising agents. Optimal stability occurred between pH 8 and 10, however the presence of benzyl alcohol within this pH range resulted in a cloudy appearance within 3 days, so a pH of 6 was used. Increasing polysorbate 80 concentrations accelerated the degradation of allergenic peptides in 100 µg/mL venom, but improved stability at concentrations of 1 µg/mL or less. Sucrose reduced degradation of allergens Myr p 1 and Myr p 3, whilst glycerol was destabilizing. In the presence of 22% sucrose, 1.1mg/mL Jack Jumper Ant venom was stable at -18 °C and 4 °C for 12 months; following dilution to 100 µg/mL with 0.9% sodium chloride, 10mM phosphate (pH 6), 0.05% polysorbate 80 and 0.9% benzyl alcohol (giving 2% sucrose), venom was stable for 7 days when stored at 4 °C. Concentrated Jack Jumper Ant venom can be stored in 22% sucrose for 12 months, and after dilution to 100 µg/mL for clinical use, it should be discarded after 7 days.


Asunto(s)
Venenos de Hormiga/química , Desensibilización Inmunológica , Inmunoterapia , Animales , Venenos de Hormiga/inmunología , Venenos de Hormiga/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Congelación , Concentración de Iones de Hidrógeno , Hipersensibilidad/inmunología , Immunoblotting , Péptidos/inmunología , Péptidos/aislamiento & purificación , Polisorbatos/farmacología , Temperatura , Factores de Tiempo
18.
Acta Neuropathol ; 115(6): 611-22, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18386021

RESUMEN

Peroxiredoxin 6 is an antioxidant enzyme and is the 1-cys member of the peroxiredoxin family. Using two-dimensional electrophoresis and Western blotting, we have shown for the first time that, in human control and brain tissue of patient's with Alzheimer's disease (AD), this enzyme exists as three major and five minor forms with pIs from 5.3 to 6.1. Using specific cellular markers, we have shown that peroxiredoxin 6 is present in astrocytes with very low levels in neurons, but not detectable in microglia or oligodendrocytes. In control brains, there was a very low level of peroxiredoxin 6 staining in astrocytes that was confined to a "halo" around the nucleus. In AD, there were marked increases in the number and staining intensity of peroxiredoxin 6 positive astrocytes in both gray and white matter in the midfrontal cortex, cingulate, hippocampus and amygdala. Confocal microscopy using antibodies to A beta peptide, tau and peroxiredoxin 6 showed that peroxiredoxin 6 positive astrocytes are closely involved with diffuse plaques and to a lesser extent with neuritic plaques, suggesting that plaques are producing reactive oxygen species. There appeared to be little astrocytic response to tau containing neurons. Although peroxiredoxin 6 positive astrocytes were seen to make multiple contacts with tau positive neurons, there was no intraneuronal colocalization. In brain tissue of patients with AD, many blood vessels exhibited peroxiredoxin 6 staining that appeared to be due to the astrocytic foot processes. These results suggest that oxidative stress conditions exist in AD and that peroxiredoxin 6 is an important antioxidant enzyme in human brain defenses.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología , Encéfalo/metabolismo , Peroxiredoxina VI/metabolismo , Anciano , Anciano de 80 o más Años , Péptidos beta-Amiloides/metabolismo , Análisis de Varianza , Astrocitos/metabolismo , Encéfalo/patología , Recuento de Células/métodos , Electroforesis en Gel Bidimensional , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neuronas/metabolismo , Proteínas tau/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA